Impact of Final Activated Clotting Time After Transradial Coronary Stenting With Maximal Antiplatelet Therapy

MLA

Onil Gleeton, et al. “Impact of Final Activated Clotting Time After Transradial Coronary Stenting With Maximal Antiplatelet Therapy.” The American Journal of Cardiology, vol. 104, Nov. 2009, pp. 1235–40. EBSCOhost, https://doi.org/10.1016/j.amjcard.2009.06.036.

APA

Onil Gleeton, Josep Rodés-Cabau, Louis Roy, Rodrigo Bagur, Olivier Costerousse, Guy Proulx, Olivier F. Bertrand, Stéphane Rinfret, Eric Larose, & Robert De Larochellière. (2009). Impact of Final Activated Clotting Time After Transradial Coronary Stenting With Maximal Antiplatelet Therapy. The American Journal of Cardiology, 104, 1235–1240. https://doi.org/10.1016/j.amjcard.2009.06.036

Chicago

Onil Gleeton, Josep Rodés-Cabau, Louis Roy, Rodrigo Bagur, Olivier Costerousse, Guy Proulx, Olivier F. Bertrand, Stéphane Rinfret, Eric Larose, and Robert De Larochellière. 2009. “Impact of Final Activated Clotting Time After Transradial Coronary Stenting With Maximal Antiplatelet Therapy.” The American Journal of Cardiology 104 (November): 1235–40. doi:10.1016/j.amjcard.2009.06.036.